No abstract available
Keywords:
DNA methylation; NPM-ALK; anaplastic large cell lymphoma; crizotinib.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anaplastic Lymphoma Kinase
-
Biomarkers, Tumor*
-
DNA Methylation / genetics
-
Epigenesis, Genetic / drug effects
-
Humans
-
Lymphoma, Large-Cell, Anaplastic / diagnosis
-
Lymphoma, Large-Cell, Anaplastic / drug therapy*
-
Lymphoma, Large-Cell, Anaplastic / genetics*
-
Lymphoma, Large-Cell, Anaplastic / metabolism
-
Molecular Targeted Therapy*
-
Protein Kinase Inhibitors / pharmacology
-
Protein Kinase Inhibitors / therapeutic use
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
-
Receptor Protein-Tyrosine Kinases / genetics
Substances
-
Biomarkers, Tumor
-
Protein Kinase Inhibitors
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases